A 
0.31
-28.82%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$1.4m
FY2016FY2025
Net income
−$2.9m
FY2016FY2025
Free cash flow
−$1.8m
FY2016FY2025
Shareholders' equity
$1.8m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4m | — | — | — | — | — | — | — | — | — |
| Gross profit | $1.4m | — | — | — | — | — | — | — | — | — |
| Research and development | $1.0m | $6.6m | $10.4m | $2.7m | $1.3m | $2.9m | $23.2m | $17.7m | $7.8m | $1.4m |
| Operating income | −$3.3m | −$11.3m | −$14.5m | −$8.0m | −$3.7m | −$5.2m | −$26.3m | −$21.8m | −$11.4m | −$2.4m |
| Net income | −$2.9m | −$11.7m | −$10.4m | −$3.6m | −$3.7m | −$5.1m | −$25.6m | −$21.5m | −$12.3m | −$3.2m |
| Diluted earnings per share | -0.93 | -7.28 | -0.41 | -2.53 | -3.06 | -4.61 | -23.33 | -30.30 | -18.44 | -5.39 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.9m | $2.7m | $1.9m | $6.8m | $4.0m | $3.2m | $8.9m | $4.5m | $22.2m | $197,000 |
| Cash and short-term investments | $2.9m | $2.6m | $1.8m | $6.7m | $3.8m | $3.1m | $8.7m | $2.7m | $21.8m | $197,000 |
| Total liabilities | $1.1m | $816,000 | $1.2m | $3.6m | $509,000 | $886,000 | $2.1m | $5.2m | $2.8m | $8.4m |
| Debt | — | — | — | — | — | — | — | — | — | $5.9m |
| Shareholders' equity | $1.8m | $2.8m | $1.6m | $3.9m | $3.5m | $2.4m | $6.8m | −$631,000 | $19.4m | −$8.2m |
| Shares outstanding | 3m | 2m | 26m | 1m | 1m | 1m | 1m | 1m | 1m | 1m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −$1.8m | −$9.0m | −$9.5m | −$7.6m | −$3.8m | −$4.6m | −$26.3m | −$18.2m | −$6.8m | −$1.6m |
| Capital spending | — | — | −$3.0m | — | — | −$1.0m | — | — | — | — |
| Free cash flow | −$1.8m | −$9.0m | −$12.5m | −$7.6m | −$3.8m | −$5.6m | −$26.3m | −$18.2m | −$6.8m | −$1.6m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.4m | — | — | — |
| Gross profit | — | — | −$1.4m | — | $1.4m | — | — | — |
| Operating income | −$707,000 | −$714,000 | −$752,000 | −$724,000 | $297,000 | −$1.9m | −$1.6m | −$3.2m |
| Net income | −$690,000 | −$695,000 | −$709,000 | −$683,000 | $335,000 | −$1.9m | −$1.5m | −$3.1m |
| Diluted earnings per share | -0.21 | -0.21 | -0.23 | -0.22 | 0.11 | -0.59 | -0.97 | -1.92 |
| Cash from operations | — | — | — | — | — | −$1.0m | — | −$2.0m |
| Total assets | $2.0m | $2.5m | $2.9m | $3.7m | $4.2m | $3.6m | $2.7m | $2.6m |
| Cash and short-term investments | $1.9m | $2.4m | $2.9m | $3.7m | $3.3m | $3.5m | $2.6m | $2.6m |
| Shareholders' equity | $569,000 | $1.2m | $1.8m | $3.6m | $4.1m | $3.5m | $2.8m | $2.6m |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Operating income | -25.8% | -8.8% | -3.8% |
| Net income | -6.4% | -10.6% | -5.7% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | -0.5 | -0.1 | -5.2 | -6.0 | -12.6 | -54.9 | -7.2 | -3.1 | -3.4 |
| Price to sales | 1.0 | — | — | — | — | — | — | — | — |
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Return | -28% | -69% | -87% | -61% | -86% | 108% | 54% | 29% | -53% |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 75-to-1 reverse split · 26 Apr 2024
- 15-to-1 reverse split · 23 Sept 2022
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.